BCL2 and lymphoma: In addition, increased transcription of the EBV BCL2 homologue, BHRF1, in Δ3C virus-infected lymphomas (as suggested in Figs 7 and 8) could potentially enhance expression of this latent viral protein may also compensate for loss of EBNA3C expression by inhibiting apoptosis [81].